11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
Details for Australian Patent Application No. 2003251410 (hide)
International Classifications
Event Publications
16 October 2003 Complete Application Filed
Priority application(s): 60/387,385 10.06.02 US
19 February 2004 Application Open to Public Inspection
Published as AU-B-2003251410
21 May 2009 Application Accepted
Published as AU-B-2003251410
17 September 2009 Standard Patent Sealed
21 January 2010 Amendment Made
The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.
11 October 2012 Alteration of Name
The name of the patentee has been altered to Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003251411-STOP-COCK SUTURE CLAMPING SYSTEM
2003251409-MATERIAL ADAPTED TO DISSIPATE AND REDUCE VIBRATIONS AND METHOD OF MAKING SAME
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser